Starting with semaglutide injection ($189/month) offers an affordable entry point
Exercise/physical activity in individuals with type 2 diabetes: a consensus statement from the American college of sports medicine
Access real-time glucose insights to understand how your meals, movement, and daily habits impact your bodyempowering you to make smarter choices that support long-term wellness and better health
Like all carnitine forms, ALCAR plays a critical role in mitochondrial fatty-acid transport
GLP-1 may harm your unborn baby
On September 19, 2025, the FDA issued Import Alert 66-80, which authorizes field staff to detain without physical examination shipments of GLP-1 active pharmaceutical ingredients (APIs) from manufacturers not included on its newly established Green List.[1] This action follows FDAs September 5 th announcement of the Green List initiative to curb illegal imports of semaglutide, tirzepatide, and other corresponding APIs.[2] Together, the Green List and Import Alert form FDAs most aggressive enforcement measures to date against GLP-1 imports